Imagine the scene. You’re planning to start a family and are faced with two choices. Either you remain on your life-saving medication which could cause physical or neurodevelopmental harm to your baby during pregnancy. Or you switch to a medication which is safer for your baby, but which could endanger your own health.
Pregnancy can be a worrying time for any parent. Will my baby be getting all the right nutrients? Am I aware of all the current high-risk foods that I should be avoiding? Is my baby growing properly?
But for women with epilepsy, that anxiety is amplified by the risks linked to many of the medications prescribed to keep their seizures under control. There are 26 drugs prescribed for epilepsy, but only two of them are thought to be safer in pregnancy.
The obvious solution would, of course, be to transfer all women of childbearing age to the safer drugs. Except that, for many women, those very drugs can cause side effects that may make life unbearable, or won’t control their seizures. And seizures themselves can be dangerous, including in pregnancy. Seizures can lead to fatality. A seizure crossing the road or standing on a platform waiting for a train could have severe consequences. Over a thousand people lose their lives to epilepsy in the UK every year - half of them to Sudden Unexpected Death in Epilepsy. Good seizure control is vital. But so is the health of an unborn baby.
One mum, whose epilepsy medication caused both physical and neurodevelopmental problems for her children, told us, “I would have taken a seizure every day of my life to avoid what they are having to suffer.”
The problem isn’t new. Some 20,000 babies are thought to have been harmed by the epilepsy medication, sodium valproate, since it was first prescribed in the 70s. The drug is now tightly regulated and can’t be prescribed unless a woman is part of a pregnancy prevention programme.
But in 2021, the Commission on Human Medicines published a report which showed that several of the other commonly prescribed epilepsy drugs also elevate risk of harm during pregnancy. Equally worrying is that, for the remaining epilepsy drugs, there isn’t enough data to evaluate the risk. When this devastating news broke, our scientists at the Epilepsy Society were able to offer real hope. Back in the 70s, when valproate was first licensed in the UK, it was impossible to look at the genetic make-up of each individual woman to understand how she and her baby might react to a particular drug.
But our greater understanding of genomics means that we can now use big data to start to identify which women will have an adverse reaction to a particular drug during pregnancy, and which drugs will be safer for them and their babies.
It’s a massive undertaking to look at the genetic blueprint of every parent and baby affected by epilepsy. But we are ready to do it. We believe it’s worth it. Research now would mean that teenagers with epilepsy could be confident that, by the time they want to have a baby, science will be able to tell them their personal risk for each medicine and ensure the healthiest outcomes possible for their pregnancy. And that is for both parent and baby.
That glimmer of hope was born three years ago, and since then we’ve been campaigning for funding that would make the research possible and the lives of future generations safer.
The stumbling block, as always, is money. We estimate it will take £20m to understand, at an individual level, which drugs elevate risk during pregnancy and which would be safer.
But, in spite of the Government’s high profile Women’s Health Strategy committing to transform women’s health, and its ambition to be a world leader in life sciences, there is still no money to carry out this vital research.
We believe the testimonies of women desperate to have a baby, but anxious about the risks, would be enough to persuade the Government to invest in healthier outcomes for the next generation. That is how it should work. But, it would seem, we also need to prove that any investment would eventually translate into a saving. Money – or how to save it - makes politicians sit up and listen.
Economists at the OHE tell us that if some of the most severe harms caused by epilepsy medications were avoided in just eight pregnancies, the Government’s investment could quickly become a saving. There doesn’t seem much to argue against there.
You could never put a price tag on a baby’s life. Every baby should be unequivocally loved, valued and celebrated for all it brings to this world. But equally we believe that every child has a right to as healthy a start in life as possible and that parents should not have to make heartbreaking choices between what is good for them and what is good for their babies.
So we fight on.
Twitter: @epilepsysociety
Website: https://epilepsysociety.org.uk/